# Decision Record

This document records validation-driven decisions for LOGOS Engine: what was decided, what evidence supports the decision, what criteria were applied, what alternatives were considered, and what risk remains.

Current state:

> No user-facing hypothesis has been accepted or refuted yet. The current decisions are planning, sequencing, boundary, and deferral decisions based on internal documentary evidence and the Validation phase structure.

The Evidence Log currently contains internal documentary evidence only. Therefore, this Decision Record must not treat the problem, audience, workflow, economics, market, or business model as externally validated.

## Decision Register

| ID | Title | Decision Type | Decision | Status | Date | Owner | Linked Evidence | Linked Experiments | Decision Gate | Confidence | Reversibility |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| DR-001 | Proceed with validation planning, not product commitment. | proceed | Continue through Research Plan, Experiments, Evidence Log, Decision Record, and Validation Report preparation while keeping Product, Engineering, GTM, and pricing commitments blocked until evidence exists. | accepted | 2026-05-14 | founder/user | EV-010, EV-011, EV-012 | EXP-01 through EXP-09 | Foundation Readiness / Validation Sequence | medium | reversible |
| DR-002 | Keep all hypotheses unaccepted and unrefuted. | defer | Do not accept or refute any hypothesis until traceable evidence is collected through research or experiments. | accepted | 2026-05-14 | founder/user | EV-011, EV-012 | all planned experiments | Evidence Quality Gate | high | reversible |
| DR-003 | Treat app-business as origin and proving ground, not as the project boundary. | revise | Maintain app-business as the founding context while validating LOGOS Engine as a broader structured-documentation engine for meaningful projects. | accepted | 2026-05-14 | founder/user | EV-003, EV-004, EV-007, CT-001 | EXP-02 | Audience and Generality Gate | medium | partially reversible |
| DR-004 | Prioritize problem and audience evidence before solution validation. | proceed | Run problem, audience, current-workaround, and cross-context research before treating solution, pricing, GTM, or business model claims as validated. | accepted | 2026-05-14 | founder/user | EV-010, EV-011, Evidence Gaps | EXP-01, EXP-02 | Gate 2: Problem and Audience Evidence | high | reversible |
| DR-005 | Defer pricing, revenue, and economic validation until value evidence exists. | defer | Keep willingness-to-pay, pricing, CAC, LTV, churn, margin, break-even, and revenue-stream decisions deferred until problem and workflow value are supported. | accepted | 2026-05-14 | founder/user | EV-013, EV-014, CT-005 | EXP-08, EXP-09 | Later Economic Gate | high | reversible |
| DR-006 | Preserve Foundation boundaries as validation constraints. | proceed / monitor risk | Treat Local First, user-owned decisions, no hidden remote state, no false authority, and structured clarity over polished output as constraints for evaluating demand and business-model paths. | accepted | 2026-05-14 | founder/user | EV-006, EV-008, EV-009, CT-002 | EXP-04, EXP-06, EXP-09 | Boundary and Trust Gate | medium | partially reversible |
| DR-007 | Use planned experiments as the evidence acquisition path. | proceed | Use EXP-01 through EXP-06 as the initial validation sequence, with adoption, retention, and willingness-to-pay experiments delayed until upstream evidence exists. | accepted | 2026-05-14 | founder/user | EV-010, EV-012, Evidence Gaps | EXP-01 through EXP-09 | Validation Sequence | high | reversible |

### DR-001: Proceed with Validation Planning, Not Product Commitment

**Context:** Foundation and Validation documents are now coherent enough to define assumptions, hypotheses, research, experiments, evidence logging, economic questions, and business-model questions. However, no external user evidence exists.

**Linked hypotheses:** all hypotheses remain untested or deferred.

**Linked assumptions:** all critical assumptions remain unresolved.

**Criteria applied:**

- Foundation artifacts are internally consistent enough to plan validation.
- Evidence Log shows no external validation yet.
- Validation Strategy requires staged evidence before product, engineering, GTM, or pricing commitments.

**Options considered:**

- Proceed directly to Product/Engineering: rejected because evidence is insufficient.
- Stop entirely: rejected because the project has enough internal coherence to justify validation.
- Proceed with validation planning only: accepted.

**Rationale:** Internal documentary evidence is enough to justify structured validation work, but not enough to justify product commitments.

**Consequences:** Research and experiments may proceed. Product scope, engineering architecture, pricing, GTM, and business model execution remain blocked by evidence gaps.

**Downstream implications:** Validation Report can later summarize readiness. Product and GTM briefs should wait for evidence-backed decisions.

**Remaining risks:** planning may create false confidence if downstream teams treat planned experiments as results.

**Monitoring plan:** Evidence Log must distinguish internal evidence from external validation.

**Revisit trigger:** after EXP-01 and EXP-02 produce evidence.

### DR-002: Keep All Hypotheses Unaccepted and Unrefuted

**Context:** The Hypotheses document marks all hypotheses as untested or deferred, and the Experiments document records no completed experiments.

**Linked hypotheses:** all.

**Criteria applied:**

- No interview evidence exists.
- No behavioral evidence exists.
- No quantitative evidence exists.
- No experiment results exist.
- Evidence strength does not support accepting or refuting any hypothesis.

**Options considered:**

- Accept internally supported hypotheses: rejected because internal coherence is not validation.
- Refute unsupported hypotheses: rejected because lack of evidence is not refutation.
- Keep hypotheses open: accepted.

**Rationale:** A hypothesis decision requires evidence strength and confidence. Current evidence can support experiment design but not validation conclusions.

**Consequences:** All hypothesis sections below remain empty until evidence is collected.

**Remaining risks:** stakeholders may interpret detailed planning documents as evidence.

**Monitoring plan:** Decision Record must only update hypothesis status when Evidence Log entries support it.

**Revisit trigger:** after each completed experiment batch.

### DR-003: Treat App-Business as Origin and Proving Ground, Not Boundary

**Context:** Old documents framed App Business as the first use case. Foundation documents and user guidance clarify that the project itself is for any meaningful project requiring structured documentation before execution.

**Linked hypotheses:** H-AU-02, H-AU-03.

**Linked assumptions:** A-TH-04, A-AU-01.

**Criteria applied:**

- Project boundaries must reflect current strategic intent.
- App-business remains useful as a concrete proving ground.
- Broader applicability is not validated and must be tested.

**Options considered:**

- Domain-lock LOGOS Engine to app-business: rejected because it conflicts with current Foundation framing.
- Generalize immediately without evidence: rejected because it creates false confidence.
- Use app-business as origin while testing generality: accepted.

**Rationale:** This preserves the founder-origin insight without narrowing the entire project prematurely.

**Consequences:** EXP-02 must test at least one non-app project type. Product and profile expansion should not assume broad generality until evidence exists.

**Remaining risks:** broad framing may become vague; app-business examples may still dominate perception.

**Monitoring plan:** Track whether non-app contexts show similar ambiguity and documentation pain.

**Revisit trigger:** after EXP-02 or contradictory audience evidence.

### DR-004: Prioritize Problem and Audience Evidence Before Solution Validation

**Context:** Validation Strategy states that problem and audience must be tested before solution, economics, and GTM claims.

**Linked hypotheses:** H-PR-01, H-PR-02, H-PR-03, H-AU-01, H-AU-02, H-AU-03, H-BE-01.

**Criteria applied:**

- If the problem is weak, solution validation is misleading.
- If the audience is wrong, workflow and pricing evidence may point in the wrong direction.
- Current evidence gaps identify user problem and audience evidence as critical.

**Options considered:**

- Start with prototype and solution testing: rejected as premature unless explicitly framed as exploratory.
- Start with pricing/economics: rejected as premature.
- Start with problem, audience, current alternatives, and cross-context research: accepted.

**Rationale:** Upstream validation reduces the risk of building around internal assumptions.

**Consequences:** EXP-01 and EXP-02 should be run before EXP-03 through EXP-09 are interpreted as validation.

**Remaining risks:** delaying prototype exposure may slow learning about workflow quality.

**Monitoring plan:** Allow lightweight prototype preparation, but do not treat solution reactions as validation until upstream evidence exists.

**Revisit trigger:** after the first research batch.

### DR-005: Defer Pricing, Revenue, and Economic Validation Until Value Evidence Exists

**Context:** Economic Model and Business Model explicitly state that pricing, revenue, CAC, LTV, churn, margin, and break-even are not validated.

**Linked hypotheses:** H-WP-01, H-WP-02, H-RE-01, H-RE-02.

**Criteria applied:**

- Willingness-to-pay evidence is weak before problem and workflow value are observed.
- Compliments, curiosity, stars, signups, or concept praise are not economic validation.
- Pricing could distort product strategy if introduced too early.

**Options considered:**

- Set provisional prices now: rejected.
- Run pricing interviews immediately: rejected unless value evidence exists.
- Defer economic validation and define future evidence needs: accepted.

**Rationale:** Economic planning is useful, but economic decisions require evidence that users value the workflow enough to exchange money, time, trust, or workflow change.

**Consequences:** EXP-09 remains deferred. Pricing and Packaging should not proceed beyond hypotheses.

**Remaining risks:** deferred economic questions may hide sustainability problems.

**Monitoring plan:** Track early value signals, support burden, and possible payer/user distinctions.

**Revisit trigger:** after EXP-03, EXP-04, EXP-06, and EXP-08 produce evidence.

### DR-006: Preserve Foundation Boundaries as Validation Constraints

**Context:** Foundation boundaries define what demand should not count as valid demand for this thesis: hidden remote-first state, autonomous decisions, generic chatbot behavior, no-code execution, project management sprawl, and polished output over structure.

**Linked hypotheses:** H-SO-02, H-SO-05, H-SO-06, H-WP-01.

**Linked assumptions:** A-TR-01, A-TR-02, A-TR-03, A-TE-02, A-MK-02.

**Criteria applied:**

- Demand that requires violating identity boundaries should trigger revision or rejection, not automatic scope expansion.
- Trust and safety are part of the product value, not afterthoughts.
- AI output should not become confirmed decision state without user review.

**Options considered:**

- Treat any strong demand as valid: rejected because it may pull toward generic SaaS, automation, or lock-in.
- Treat boundaries as immutable forever: rejected because some deferred scope may be validated later.
- Use boundaries as validation constraints and revisit only with evidence: accepted.

**Rationale:** Validation should test the thesis, not reshape it silently to fit any demand signal.

**Consequences:** Experiments and business-model decisions must record when user demand conflicts with Local First, user ownership, explicit AI boundaries, or structured clarity.

**Remaining risks:** constraints may exclude adjacent demand that could represent a viable pivot.

**Monitoring plan:** Log boundary-conflicting demand as contradictory evidence, not as immediate scope.

**Revisit trigger:** repeated strong demand from the intended audience that conflicts with a current boundary.

### DR-007: Use Planned Experiments as the Evidence Acquisition Path

**Context:** The Experiments document defines planned experiments with criteria and no results.

**Linked hypotheses:** all.

**Criteria applied:**

- Each experiment links to hypotheses and decision gates.
- Evidence Log identifies evidence gaps that map to EXP-01 through EXP-09.
- Experiment results must feed Evidence Log before Decision Record updates.

**Options considered:**

- Collect ad hoc evidence without protocol: rejected because it weakens traceability.
- Run all experiments in parallel: rejected because downstream tests depend on upstream evidence.
- Use planned experiments in dependency order: accepted.

**Rationale:** The experiment register provides the cleanest path from evidence gap to decision.

**Consequences:** Decision updates should cite experiment outputs and Evidence Log entries after execution.

**Remaining risks:** protocols may need revision after first contact with real users.

**Monitoring plan:** If a protocol proves leading, too heavy, unsafe, or unable to change a decision, mark the experiment invalidated or revise before continuing.

**Revisit trigger:** after each experiment batch or major protocol deviation.

## Accepted Hypotheses

No hypotheses have been accepted as supported.

| Hypothesis | Decision | Evidence Basis | Evidence Strength | Confidence | Limitations | Impact | Follow-Up Needed | Status |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| All hypotheses | not accepted | Evidence Log contains internal documentary evidence only; no external user, behavioral, quantitative, market, or experiment evidence exists. | insufficient | high confidence in non-acceptance status | Current internal evidence can guide tests but cannot validate claims. | Keeps Product, GTM, pricing, and business-model commitments blocked. | Run planned research and experiments. | open |

## Refuted Hypotheses

No hypotheses have been refuted.

| Hypothesis | Decision | Evidence Basis | Evidence Strength | Confidence | Limitations | Impact | Follow-Up Needed | Status |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| All hypotheses | not refuted | Absence of external evidence is not refuting evidence. | insufficient | high confidence in non-refutation status | Negative or contradictory user evidence has not yet been collected. | Prevents premature stopping or pivoting based on lack of data alone. | Run planned research and preserve contradictory evidence. | open |

## Pivot Decisions

No evidence-driven pivot has been made yet.

The closest current decision is DR-003, which is classified as a **revision/clarification**, not a validation pivot: app-business remains the origin and proving ground, while the broader project is validated as potentially applicable to any meaningful project requiring structured documentation before execution.

| Pivot Candidate | Status | Trigger Needed | Affected Documents |
| --- | --- | --- | --- |
| Narrow project to app-business only. | not decided | Evidence that pain or workflow value does not generalize beyond app-business. | Audience, Boundaries, Product Scope, Profile Strategy. |
| Pivot to consultant/agency intake. | not decided | Evidence that consultants/agencies show stronger pain, buyer value, or repeat use than solo builders. | Audience, Business Model, GTM, Product Scope. |
| Pivot away from AI-led intake. | not decided | Evidence that AI-led intake creates false confidence, low traceability, or unacceptable friction. | Product, Engineering, AI behavior, UX. |
| Pivot away from local-first primary model. | not decided | Strong evidence that intended users reject local-first and boundary-safe alternatives exist. | Principles, Boundaries, Engineering, Business Model. |

## Proceed Decisions

Proceed decisions currently authorize validation work only.

| Decision | What Can Proceed | What Remains Blocked | Conditions | Monitoring |
| --- | --- | --- | --- | --- |
| DR-001 | Validation planning, research preparation, experiment preparation, evidence logging. | Product commitment, engineering architecture, pricing, GTM execution. | Evidence remains clearly labeled by strength and source. | Evidence Log quality review. |
| DR-004 | EXP-01 and EXP-02 as first evidence collection priorities. | Solution, economic, and GTM validation conclusions. | Problem/audience questions must precede solution pitch. | Interview notes and participant fit. |
| DR-006 | Boundary-aware experiment and business-model evaluation. | Revenue or product paths that require boundary violations. | Boundary-conflicting demand must be logged as contradiction. | Open risks and contradictory evidence. |
| DR-007 | Planned experiments as evidence acquisition path. | Treating planned protocols as results. | Experiment outputs must go to Evidence Log first. | Experiment status and protocol deviations. |

## Stop Decisions

No stop decision has been made.

Stop conditions remain defined in the Validation Strategy, Economic Model, Business Model, and Evidence Log but have not been triggered.

Potential future stop decisions include:

- stop or reframe if intended users do not recognize the problem;
- stop or revise if structured documentation does not create more clarity than alternatives;
- stop a revenue path if it requires hidden remote state, autonomous decisions, lock-in, or output-volume incentives;
- stop broad profile expansion if one or a few profiles do not validate the core mechanism;
- stop pricing validation if workflow value is not demonstrated first.

## Deferred Decisions

| Decision | Why Deferred | Evidence Needed | Blocking Impact | Revisit Trigger | Status |
| --- | --- | --- | --- | --- | --- |
| Accept or refute H-PR-01 through H-PR-03. | No user problem evidence exists. | EXP-01 interviews and artifact review. | Blocks product and GTM confidence. | Completion of first problem research batch. | deferred |
| Choose the first validated audience segment. | Audience is currently hypothesized, not proven. | EXP-01 and EXP-02 evidence. | Blocks positioning, onboarding, and product focus. | Audience evidence shows repeated pain and workflow fit. | deferred |
| Validate generality beyond app-business. | Cross-context evidence is missing. | EXP-02. | Blocks broad profile expansion. | At least one non-app context shows similar pain and workflow value. | deferred |
| Validate AI-led intake. | No prototype or concierge intake evidence exists. | EXP-04. | Blocks AI workflow commitments. | Users safely review proposed decisions from real sessions. | deferred |
| Validate structured documents over generic prose. | No artifact comparison evidence exists. | EXP-03. | Blocks core documentation-mechanism confidence. | Participants prefer decision-derived docs for clarity, not polish. | deferred |
| Decide whether diagnostics are core. | No diagnostic actionability evidence exists. | EXP-05. | Blocks diagnostic roadmap priority. | Users can explain diagnostics and choose next actions. | deferred |
| Decide whether local-first is a market advantage. | Trust evidence is internal only. | EXP-06. | Blocks architecture and positioning confidence. | Users value local files, inspectability, and provider disclosure. | deferred |
| Decide pricing and packaging. | No value or willingness-to-pay evidence exists. | EXP-09 after EXP-03/04/06/08. | Blocks pricing and financial operations. | Users connect value to money, time, trust, or workflow change. | deferred |
| Decide business-model path. | Business model is coherent but unproven. | EXP-07, EXP-08, EXP-09 plus cost/support evidence. | Blocks GTM and operations commitments. | Evidence identifies buyer, revenue stream, channel, and support model. | deferred |
| Decide hosted collaboration or enterprise path. | Deferred by boundaries and no demand evidence. | Future research after local value is proven. | Blocks hosted/team/enterprise scope. | Strong boundary-safe demand appears. | deferred |

## Reopened Decisions

No decisions have been reopened yet.

Reopening rules:

- A decision should be reopened when new evidence contradicts its evidence basis, criteria, or assumptions.
- Reopened decisions must cite the original decision ID.
- A reopened decision may be reaffirmed, revised, reversed, or deferred again.
- Reopened decisions must update downstream documents if they affected Product, Engineering, GTM, Operations, or Validation Report.

Likely future reopening triggers:

- user evidence contradicts the broad audience framing;
- diagnostics are found to be noisy or unactionable;
- local-first setup blocks adoption;
- AI-led intake creates false confidence;
- willingness-to-pay evidence points to a different buyer or segment;
- economic sustainability requires a boundary violation.

## Open Risks

| Risk | Status | Evidence Basis | Accepted Risk Level | Owner | Monitoring Signal | Mitigation | Revisit Trigger | Downstream Impact |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Problem may not be painful enough. | open | Evidence Gap: no user problem evidence. | high until EXP-01 | founder/user | Participants fail to describe costly ambiguity. | Run EXP-01 before solution commitments. | First research batch. | Product and GTM blocked. |
| Audience may be too broad or wrong. | open | CT-001, no audience evidence. | high | founder/user | Pain appears only in one segment or not in primary audience. | Run EXP-01 and EXP-02. | Audience pattern emerges. | Product, profiles, GTM affected. |
| Structured rigor may create too much friction. | open | CT-004. | high | founder/user | Users abandon, skim, or reject decision review/diagnostics. | Run EXP-04, EXP-05, EXP-06; simplify workflow if needed. | Prototype session evidence. | UX, product scope, AI behavior. |
| AI may create false authority. | open | Boundaries, EV-008, no workflow evidence. | high | founder/user | Users treat proposed decisions as confirmed. | Preserve proposed/confirmed distinction; test in EXP-04. | Decision-review confusion. | Product safety and trust. |
| Local-first may be project preference, not user value. | open | EV-006, no trust behavior evidence. | medium-high | founder/user | Users prefer hosted state or ignore inspectability. | Run EXP-06; log boundary conflicts. | Trust review evidence. | Architecture and positioning. |
| Open-source may not sustain maintenance. | open | CT-003, Economic Model. | medium | founder/user | Attention without funding, contribution, or paid value. | Track support burden; defer business model decisions. | Post-value economic evidence. | Operations and financial model. |
| Pricing may distort product direction. | monitored | DR-005, Economic Model. | medium | founder/user | Pricing pressure rewards output volume or lock-in. | Defer pricing; price around clarity/support/profile value later. | EXP-09 readiness. | GTM and Product boundaries. |
| Planned experiments may be mistaken for validation. | monitored | EV-012, DR-001. | medium | founder/user | Docs or downstream artifacts cite protocols as results. | Keep Evidence Log and Decision Record explicit. | Validation Report drafting. | Product and GTM readiness. |

## Downstream Implications

### Product

Product work may use the Foundation and Validation documents as constraints, but it should not assume validated demand yet. Product Brief and Product Scope should wait for evidence from EXP-01 through EXP-06 or explicitly mark assumptions as unvalidated.

### Engineering

Engineering may prepare for local-first, structured state, Markdown rendering, AI proposal review, diagnostics, and safe defaults as product constraints. However, large architecture commitments around hosted collaboration, marketplace, broad profile expansion, or enterprise features remain blocked.

### Go-to-market

GTM may prepare message hypotheses around "clarity before execution" and local-first structured documentation. It must not claim market demand, adoption, pricing, or channel performance yet.

### Operations

Operations should prepare evidence capture, research notes, support-burden tracking, AI/API cost tracking, and decision governance. It should not assume scale, support load, community contribution, or revenue.

### Validation Report

Validation Report should treat this Decision Record as a record of current planning and deferral decisions. It should not report any accepted/refuted hypothesis until research or experiments produce evidence.

## Decision Rules Going Forward

- Evidence must be logged in Evidence Log before it changes a decision.
- Hypotheses require evidence strength and confidence before acceptance or refutation.
- Deferred decisions are not resolved decisions.
- Proceed decisions must carry remaining risks.
- Boundary-conflicting demand must be logged as contradictory evidence before it becomes scope.
- Pricing and business-model decisions must wait for value evidence.
- Decisions that affect Foundation, Product, Engineering, GTM, or Operations must state downstream implications explicitly.
